A joint position statement by the Society for Endocrinology and Obesity Management Collaborative UK
This position statement is aimed at healthcare professionals working within weight management services, organisations delivering medical therapies for patients living with obesity, and commissioners of such services. Its objectives are to:
- Ease the impact of rolling out GLP-1 analogues and future drugs for obesity on NHS resources.
- Offer some suggestions on the prioritisation of patients most in need of weight loss for specific medical reasons.